Flexor Hallucis Longus Tendon Transfer VS Gastrocnemius Augmented Flexor Hallucis Longus Tendon Transfer in Management of Achilles Tendon Defect
Launched by ASSIUT UNIVERSITY · Feb 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for repairing the Achilles tendon, which is a crucial tendon located at the back of your ankle. Specifically, it will compare a standard procedure called Flexor Hallucis Longus tendon transfer with another method that adds support from a muscle called the gastrocnemius. The goal is to see which method works better in helping patients recover, how quickly they can get back to their normal activities, and if one method has fewer complications or requires more follow-up surgeries.
To participate in this trial, you need to be an adolescent or adult with a specific type of Achilles tendon injury that is longer than 4 centimeters, whether from an injury or a long-standing problem. Unfortunately, if you have certain medical conditions, previous surgeries in the same area, or other specific issues, you may not be eligible. If you join the trial, you will help researchers understand the best ways to treat these injuries, which could lead to improved care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age range: Adolescents and adults with skeletally mature feet (above 12 y in females and 14 years in males).
- • Achilles Tendon defects more than 4 cm resulted from acute or chronic rupture, post-debridement defects in case of neglected insertional tendinopathy, spontaneous ruptures due to tendinosis or after tumor resection.
- Exclusion Criteria:
- • General medical contraindications to surgical interventions
- • Calcaneal Fracture, subtalar fusion
- • infection or previous surgery in the ipsilateral hindfoot or ankle
- • Systemic disease including seronegative inflammatory diseases, spondyloarthropathies or sarcoidosis.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported